Is the outcome of elective vs non-elective patients undergoing transcatheter aortic valve implantation different? Results of a single-centre, observational assessment of outcomes at a large university clinic

Table 3 Factors associated with TAVI fast-track protocol failure

	Fast-Track (n = 172)	No fast-track (n = 204)	Crude OR (95% CI)	P-value	Adjusted OR (95% CI)	p-value
*Baseline characteristics*
Frailty syndrome^a, n [%]	9 (5.2)	52 (25.5)	6.20 (2.95–13.00)	< 0.001	5.15 (2.40–11.09)	< 0.001
eGFR < 60 mL/min/1.73m², n [%]	85 (49.4)	123 (60.3)	1.55 (1.03–2.34)	0.035	0.87 (0.54–1.38)	0.550
*Procedural factors*
New PPI, n [%]	6 (3.5)	41 (20.1)	6.96 (2.88–16.84)	< 0.001	6.44 (2.59–16.00)	< 0.001
NBBB or atrial fibrillation, n [%]	29 (16.9)	54 (26.5)	1.78 (1.07–2.94)	0.026	1.59 (0.92–2.75)	0.100
Type 3 (life-threatening) bleeding, n [%]	8 (4.7)	30 (14.7)	3.53 (1.57–7.93)	0.002	4.19 (1.82–9.66)	< 0.001
Self-expanding valve, n [%]	88 (51.2)	127 (62.3)	1.57 (1.04–2.38)	0.031	1.35 (0.86–2.13)	0.191

Legend: Results are presented as crude and adjusted odds ratios (OR) with 95% confidence interval (CI) for non-fast-track versus fast-track TAVI
eGFR estimated glomerular filtration rate, NBBB new bundle branch block, PPI permanent pacemaker implantation, TAVI transcatheter aortic valve implantation
^aFrailty syndrome was clinically diagnosed without specific frailty assessment tools

ISSN: 1471-2261